Schizophrenia Bulletin Advance Access published online on November 13, 2009
Schizophrenia Bulletin, doi:10.1093/schbul/sbp126
Cannabis and First-Episode Psychosis: Different Long-term Outcomes Depending on Continued or Discontinued Use
2 Centro de Investigación Biomédica en Red de Salud Mental, Hospital Santiago Apóstol, University of the Basque Country, Vitoria, Spain
3 Basque Foundation for Health Innovation and Research, Vizcaya, BIOEF, CIBERESP, Sondica (Vizcaya), Spain
4 Bipolar Disorder Program, Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain
5 Adolescent Unit, Department of Psychiatry, Hospital General Universitario Gregorio Marañón, Centro de Investigación Biomédica en Red de Salud Mental, Madrid, Spain
1 To whom correspondence should be addressed; Department of Psychiatry, Centro de Investigación Biomédica en Red de Salud Mental, Hospital Santiago Apóstol, University of the Basque Country, Olaguibel 29, Vitoria, Spain; tel: +34-945-007770, fax: +34-945-007764, e-mail: ANAMARIA.GONZALEZ-PINTOARRILLAGA{at}osakidetza.net.
Objective: To examine the influence of cannabis use on long-term outcome in patients with a first psychotic episode, comparing patients who have never used cannabis with (a) those who used cannabis before the first episode but stopped using it during follow-up and (b) those who used cannabis both before the first episode and during follow-up. Methods: Patients were studied following their first admission for psychosis. They were interviewed at years 1, 3, and 5. At follow-up after 8 years, functional outcome and alcohol and drug abuse were recorded. Patients were classified according to cannabis use: 25 had cannabis use before their first psychotic episode and continuous use during follow-up (CU), 27 had cannabis use before their first episode but stopped its use during follow-up (CUS), and 40 never used cannabis (NU). Results: The 3 groups did not differ significantly in symptoms or functional outcome at baseline or during short-term follow-up. The CUS group exhibited better long-term functional outcome compared with the other 2 groups and had fewer negative symptoms than the CU group, after adjusting for potential confounders. For the CUS group, the effect size was 1.26 (95% confidence interval [CI] = 0.65 to 1.86) for functional outcome and –0.72 (95% CI = –1.27 to –0.14) for negative symptoms. All patients experienced improvements in positive symptoms during long-term follow-up. Conclusion: Cannabis has a deleterious effect, but stopping use after the first psychotic episode contributes to a clear improvement in outcome. The positive effects of stopping cannabis use can be seen more clearly in the long term.
Keywords: cannabis / first-episode psychosis / outcome / follow-up / discontinued use